Reuters logo
BRIEF-Reata Pharmaceuticals Q3 loss per share $0.50
November 13, 2017 / 12:45 PM / in 8 days

BRIEF-Reata Pharmaceuticals Q3 loss per share $0.50

Nov 13 (Reuters) - Reata Pharmaceuticals Inc

* Reata Pharmaceuticals Inc announces third quarter 2017 financial and operating results

* Q3 loss per share $0.50

* Q3 earnings per share view $-0.41 -- Thomson Reuters I/B/E/S

* Reata Pharmaceuticals Inc - qtrly ‍total collaboration revenue $12.6 million versus $12.6 million

* Reata Pharmaceuticals Inc - ‍as of September 30, 2017, company had $154.6 million in cash and cash equivalents​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below